Cannabinoids to Treat Serious Neurological and Inflammatory Conditions
Related Articles
FSD Pharma Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint
November 14, 2018
admin
Healthcare, Newsmakers
Comments Off on FSD Pharma Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint
TORONTO, Nov. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company“) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) under the […]
Medicine Man Technologies (OTC: MDCL) Fast Growing Revenues & Profits in Marijuana “Picks & Shovels”
December 7, 2018
admin
CEO Interview
Comments Off on Medicine Man Technologies (OTC: MDCL) Fast Growing Revenues & Profits in Marijuana “Picks & Shovels”
Note: This interview published December 7, 2018. Please see updated interview January 24, 2019 here Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, […]
FSD Pharma (OTC: FSDDF) Completes Harvest and Passes Analytical Testing of Second Lot
January 10, 2019
admin
Newsmakers
Comments Off on FSD Pharma (OTC: FSDDF) Completes Harvest and Passes Analytical Testing of Second Lot
Company in position for pre-sales license inspection, last step to issuance of a Sales License FSD Pharma Inc. (“FSD Pharma” or the “Company”) (OTC: FSDDF) (cse:HUGE)(fra:0K9) is pleased to announce that its wholly-owned subsidiary, FV […]